{
    "eid": "2-s2.0-85006413295",
    "title": "Rituximab for recurrent IgA nephropathy in kidney transplantation: A report of three cases and proposed mechanisms",
    "cover-date": "2017-01-01",
    "subject-areas": [
        {
            "$": "Nephrology",
            "@code": "2727"
        }
    ],
    "keywords": [
        "kidney transplantation",
        "recurrent IgA nephropathy",
        "rituximab"
    ],
    "authors": [
        "Wiwat Chancharoenthana"
    ],
    "citedby-count": 19,
    "ref-count": 22,
    "ref-list": [
        "Recurrent glomerulonephritis after kidney transplantation",
        "Exclusive characteristics of graft survival and risk factors in recipients with immunoglobulin A nephropathy: A retrospective analysis of registry data",
        "Recurrent IgA nephropathy in the renal allograft: Not a benign condition",
        "KDIGO clinical practice guideline for the care of kidney transplant recipients.",
        "KDIGO clinical practice guideline for the care of kidney transplant recipients: A summary",
        "A clinicopathological study of IgA nephropathy in renal transplant recipients: Beneficial effect of angiotensin-converting enzyme inhibitor",
        "Renin angiotensin system blockade in kidney transplantation: A systematic review of the evidence",
        "Evaluating the Clinical Course and Prognostic Factors of Posttransplantation Immunoglobulin A Nephropathy",
        "Renal transplantation in patients with IgA mesangial glomerulonephritis",
        "Recurrent and de novo disease after renal transplantation: A report from the Renal Allograft Disease Registry",
        "Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis",
        "Proteinuria-reducing effects of tonsillectomy alone in IgA nephropathy recurring after kidney transplantation",
        "IgA nephropathy with crescents in kidney transplant recipients",
        "Mortality in rheumatoid arthritis: The impact of disease activity, treatment with glucocorticoids, TNF\u03b1 inhibitors and rituximab",
        "Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis",
        "Rituximab-based novel strategies for the treatment of immune-mediated glomerular diseases",
        "Rituximab in idiopathic membranous nephropathy: A one-year prospective study",
        "Effect of single-dose rituximab on primary glomerular diseases",
        "Early recurrence of active IgA nephropathy after kidney transplantation",
        "A review of the current use of rituximab in autoimmune diseases",
        "Antithymocyte globulin (ATG) induction therapy and disease recurrence in renal transplant recipients with primary iga nephropathy",
        "Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulabhorn Royal Academy",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}